Company profile for Advicenne

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

At Advicenne, we are committed to innovating in the areas of formulation and clinical development. Tasteless and easy to administer, ADV7103 will be commercialized in small-size formats that offer flexible, personalized dosing – because pathbreaking treatments for rare diseases should be available to patients of all ages.Headquartered in Nîmes, France, Advicenne was listed on the Euronext Paris stock exchange in December 20...
At Advicenne, we are committed to innovating in the areas of formulation and clinical development. Tasteless and easy to administer, ADV7103 will be commercialized in small-size formats that offer flexible, personalized dosing – because pathbreaking treatments for rare diseases should be available to patients of all ages.Headquartered in Nîmes, France, Advicenne was listed on the Euronext Paris stock exchange in December 2017

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
France
Address
Address
22 Rue de la Paix – 3ème étage F-75002 Paris
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

Global ChemShow

Not Confirmed

envelop Contact Supplier

Global ChemShow

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.pharmiweb.com/press-release/2025-09-19/advicenne-reports-first-half-financial-results-as-of-june-30-2025-and-updates-on-its-activities

PHARMAWEB
19 Sep 2025

https://www.pharmiweb.com/press-release/2025-08-26/advicenne-announces-the-publication-in-orphanet-journal-of-rare-diseases-of-the-long-term-european-s

PHARMAWEB
26 Aug 2025

https://www.globenewswire.com/news-release/2022/01/04/2360580/0/en/Advicenne-announces-commercialization-agreement-with-FrostPharma-AB-for-Sibnayal-in-the-Nordic-region.html

GLOBENEWSWIRE
04 Jan 2022

https://www.globenewswire.com/news-release/2021/12/20/2355098/0/en/Advicenne-announces-positive-opinion-from-the-French-Transparency-Commission-HAS-for-its-drug-SibnayalTM-in-dRTA.html

GLOBENEWSWIRE
20 Dec 2021

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty